Page 561 - Enfeksiyon Hastalıkları Kitabı

Kaynaklar 541

Usluer G. Antifungal ilaçlar. In: Fungal İnfeksiyonlar (Yazarlar; Weisfelt M, van de Beek D, Spanjaard L, et al. Arthritis in adults
Ulusoy S, Arman D, Uzun Ö). 2. baskı. Bilimsel Tıp Ya yınevi, with community-acquired bacterial meningitis: a prospecti-
Ankara; 2012. ve cohort study. BMC Infect Dis 2006;6:64
Uysal A, Taner CE, Cüce M, et al. Cytomegalovirus and rubella West Nile Virus Fact sheet 354 July 2011.who.int. 13 Kasım 2012.
seroprevalence in pregnant women in Izmir/Turkey: follow- http://www.who.int/mediacentre/factsheets/fs354/en/
up and results of pregnancy outcome. Arch Gynecol Obstet
2012;286:605-608. West Nile Virus: What You Need To Know.cdc.gov. 13 Kasım
2012. http://www.cdc.gov/ncidod/dvbid/westnile/wnv_fact-
Vaara M. Polymyxins and their novel derivatives. Curr Opin Sheet.htm
Microbiol 2010;13:574-581.
Weström L, Eschenbach D. Pelvic inflammatory disease. In: Hol-

Van Bambeke F, Michot JM, Vn Eldere J, Tulkens PM. Quinolo- mes KK, Sparling PF, Märdh PA, et al. ed. Sexually transmit-
nes in 2005: an update. Clin Microbiol Infect 2005;11:256- ted diseases, New York: McGraw-Hill; 1999:783-809.
280.
WHO Global Malaria Programme, World Malaria Report, 2012.
Van Bambeke F, Van Laethem Y, Courvalin P et al. Glycopeptide http://www.who.int/malaria/publications/world_malaria_
antibiotics: from conventional molecules to new derivatives. report_2012/wmr2012_full_report.pdf
Drugs. 2004;64(9):913-936.
Williams B. Infectious diseases history: A guide to causes and
Vedat Turhan. “Enfeksiyon Hastalıkları Uzmanlık Dalının Ta- effects. Urbanrim. for distribution within the Department of

rihçesi”, Ulusal EKMUD Bilimsel Platformu, 1-5 Mart 2011, Economic and Social History at the University of Hull, Eng-
İstanbul. land. 1997 http://www.urbanrim.org.uk/diseases.htm
Vilhena C, Bettencourt A. Daptomycin: a review of properti- Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective
es, clinical use, drug delivery and resistance. Mini Rev Med endocarditis: guidelines from the American Heart Associa-
Chem. 2012;12:202-209. tion. Circulation. 2007;116:1736-1754.
Vinh H, Baker S, Campbell J, et al. Rapid emergence of third Wilson W.R,N.K. Henry çev: H.Leblebicioğlu Üriner Sistem İn-
generation cephalosporin resistant Shigella spp. in southern feksiyonları. Current Enfeksiyon Hastalıkları Tanı ve Tedavi
Vietnam. J Med Microbiol 2009; 58: 281-283. (Çeviri Yazarı; Leblebicioğlu H) 2004.
Viscoli C, Varnier O, Machetti M. Infection in Patients with Wilson ME, Weld LH, Boggild A, et al: Fever in returned tra-
Febrile Neutropenia: Epidemiology, Microbiology and Risk velers: results from the GeoSentinel Surveillance Net-

Stratification. Clin Infect Dis; 2005:40(4):240-245. work. Clin Infect Dis 2007; 44:1560-1568.
Volberding PA, Deeks SG. Antiretroviral therapy and manage- Winter M E. Basic Clinical Pharmacokinbetics 15. th edition.
ment of HIV infection. Lancet 2010; 376: 49- 62. Wolters Kluwer Lippincott Williams and Wilkins. USA; 2010.
Vouloumanou EK, Karageorgopoulos DE, Rafailidis PI, Micha- Wong CH, Khin LW, Heng KS,Tan KC, Low CO. (2004) Th e
lopoulos A, Falagas ME. Trimethoprim/sulfametrole: evalu- LRINEC (Laboratory risk indicator for necrotizing fasciitis)
ation of the available clinical and pharmacokinetic/pharma- score: A tool for distinguishing necrotizing fasciitis from ot-
codynamic evidence. J Antimicrob Agents 2011; 38:197-216. her soft tissue infections. Crit Care Med 2004:32:1535-1541.
Wagenlehner FME, Wullt B, Perletti G. Antimicrobials in uro- World Health Organization. Rheumatic fever and rheumatic he-
genital infections. Int J Antimicrob Agents 2011; 38: 3-10. art disese: report of a WHO expert consultation. Geneva.
Wagner A, Wiedermann U. Travellers’ diarrhoea - pros and cons WHO, 20 Oct to 1 Nov 2001. WHO Tech Rep Ser 2001:923.

of different prophylactic measures. Wien Klin Wochenschr Wright SG. Protozoan infections of the gastrointestinal tract.
2009; 121: 13-18. Infect Dis Clin North Am. 2012 ;26(2):323-339
Walsh TJ, Finberg RW, Arndt C, et al: Liposomal amphotericin Wullt M, Odenholt I. A double-blind randomized controlled
B for empirical therapy in patients with persistent fever and trial of fusidic acid and metronidazole for treatment of an
neutropenia. N Engl J Med 1999;340:764-771. initial episode of Clostridium diffi cile-associated diarrhoea. J
Walsh TJ, Pappas P, Winston DJ, et al: Voriconazole compared Antimicrob Chemother 2004;54:211-216.
with liposomal amphotericin B for empirical antifungal the- Yaman M. Control of phlebotomine sandflies and the latest deve-

rapy in patients with neutropenia and persistent fever. N lopment in this field. Turkiye Parazitol Derg. 2008;32(3):280-

Engl J Med 2002;346:225-234.
287.
Walsh TJ, Teppler H, Donowitz GR, et al: Caspofungin versus Yamazhan T, Ulusoy S. Amebiyaz ve giardiyaz. Gastrointestinal
liposomal amphotericin B for empirical antifungal therapy sistem enfeksiyonlarının tedavisi (Yazarlar; Arman D, Usluer
in patients with persistent fever and neutropenia. N Engl J G). Bilimsel Tıp Yayınevi, Ankara, 2003.
Med 2004; 351:1391-1402.
Yates AB. Management of patients with a history of allergy to
Wanke CA. Approach to the adult with acute diarrhea in deve- beta-lactam antibiotics. Am J Med 2008; 121:572-576.
loped countries. 2013 UpToDate, Inc. ( http://www.uptodate.
com/contents/approach-to-the-adult-with-acute-diarrhea- Yıldırım M, Şahin İ, Gülcan A, et al. Antimicrobial Susceptibility
in-developedcountries? source= search_ result&search=ac and Uropathogens Isolated from Children and Adults with
ute+diarrhea&selectedTitle =1%7E94 (erişim tarihi: 7 Ocak Community-Acquired Urinary Tract Infections. Turkiye
2013) Klinikleri J Med Sci 2010;30:533–538.
Wassilak SGF, Roper MH, Kretsinger K, Orenstein WA. Tetanus Yigit N, Colak E, Sozen M, Karatas A. Rodents of Türkiye
toxoid. In: Vaccines (Eds; Plotkin SA, Orenstein WA, Offi t (Türkiye’nin kemiricileri). In: Rodents of Türkiye (Yazar; De-
PA). 5th edition. Saunders Elsevier, Philadelphia; 2008. mirsoy A). Meteksan, Ankara; 2006.